Lobby organisation
Swedish Orphan Biovitrum
Company · Health & pharma · HQ: Sweden · Transparency Register entry
As of 8 October 2026, Swedish Orphan Biovitrum appears in 4 declared MEP meetings (3 different MEPs), most often with European People's Party.
In their own words
“Sobi is a global biopharmaceutical company specialized in rare diseases developing and providing access to innovative treatments in the areas of haematology, immunology and specialty care. Sobi offers an integrated process, from in-house research and development in protein characterisation, biologics manufacturing and industrialisation, to commercialisation of products for rare diseases.”
Read the rest of the statementShow less of the statement
“Partnering with stakeholders and facilitating effective and timely rare-disease therapy development, including an extensive and robust distribution network, creates unique opportunities for us to add value to the rare-disease field.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 4 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2024. Bar length is relative to its busiest year (4 in 2024). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 4 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 27 Nov 2024 | Romana Jerković | Meeting |
| 27 Nov 2024 | András Tivadar Kulja | European health policy |
| 18 Sep 2024 | Stine Bosse | Health Policy - Rare Diseases |
| 17 Sep 2024 | András Tivadar Kulja | Rare Diseases |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.